心律失常药物治疗的若干进展
胡大一,刘兴鹏
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 胡大一,刘兴鹏
参考文献(References)：
- 1HohnloserSH ,KuckHH ,LilienthalJ ,etal.Rhythmorratecontrolinatrialfibrillation:PharmacologicalInterventioninAtrialFibrillation(PIAF):arandomizedtrial.Lancet,2000,356:17891794.
- 2TheAFFIRMInvestigators.Acomparisonofratecontrolandrhythmcontrolinpatientswithatrialfibrillation.NEnglJMed,2002,347:18251833.
- 3VanGelderIC ,HagensVE ,BoskerHA ,etal.Acomparisonofratecontrolandrhythmcontrolinpatientswithrecurrentpersistentatrialfibrillation.NEnglJMed,2002,247:18341840.
- 4CarlssonJ,MiketicS ,WindelerJ ,etal.Randomizedtrialofrate controlversusrhythm controlinpersistentatrialfibrillation:theStrategiesofTreatmentofAtrialFibrillation(STAF)study.JAmCollCardiol,2003,41:16901696.
- 5WeerasooriyaR ,DavisM ,PowellA ,etal.TheAustralianInterventionRandomizedControlofRateinAtrialFibrillationTrial(AIRCRAFT).JAmCollCardiol,2003,41:16971701.
- 6PapponeC ,AugelloG ,VicedominiG ,etal.Ablationversusmedicaltherapyforatrialfibrillation:whobenefitthemost?PacingClinElectrophysiol,2003,26(4ptⅡ):986.
- 7TheCardiacArrhythmiaSuppressionTrial(CAST )Investigators.Preliminaryreport:effectofencainideandflecainideonmortalityandarandomizedtrialofarrhythmiasuppressionaftermyocardialinfarction.NEnglJMed,1989,321:406412.
- 8ZipesDP ,WellensHJJ.Whathavewelearnedaboutcardiacarrhythmias?Circulation,2000,102(20Suppl4):IV5257.
- 9SagerPT .NewadvancesinclassIIIantiarrhythmicdrugtherapy.CurrOpinCardiol,2000,15:4153.
- 10OralH ,SouzaJJ,MichaudGF ,etal.Facilitatingtransthoraciccardioversionofatrialfibrillationwithibutilidepretreatment.NEnglJMed,1999,340:18491854.
- 11VanderLugtJT ,MattioniT ,DenkerS ,etal.Efficacyandsafetyofibutilidefumaratefortheconversionofatrialarrhythmiasaftercardiacsurgery.Circulation,1999,100:369375.
- 12SinghS ,ZobleRG ,YellenL ,etal.Efficacyandsafetyoforaldofetilideinconvertingtoandmaintainingsinusrhythminpatientswithchronicatrialfibrillationoratrialflutter:thesymptomaticatrialfibrillationinvestigativeresearchondofetilide(SAFIRE D )study.Circulation,2000,102:23852390.
- 13SinghS ,BerkM ,YellenL ,etal.Efficacyandsafetyoforaldofetilideinmaintainingnormalsinusinpatientswithatrialfibrillation flutter:amulticenterstudy.Circulation,1997,96(suppl):1383.
- 14FusterV ,RydenLE ,AsingerRW ,etal.ACC AHA ESCGuidelinesfortheManagementofPatientsWithAtrialFibrillation:ExecutiveSummaryAReportoftheAmericanCollegeofCardiologyAmericanHeartAssociationTaskForceonPracticeGuidelinesandtheEuropeanSocietyofCardiologyCommitteeforPracticeGuidelinesandPolicyConferences(CommitteetoDevelopGuidelinesfortheManagementofPatientsWithAtrialFibrillation)DevelopedinCollaborationWiththeNorthAmericanSocietyofPacingandElectrophysiology.Circulation,2001,104:2118250.
- 15TorpPedersenC ,MollerM ,BlochThomsenPE ,etal.Dofetilideinpatientswithcongestiveheartfailureandleftventriculardysfunction.DanishInvestigationsofArrhythmiaandMortalityonDofetilideStudyGroup.NEnglJMed,1999,341:857865.
- 16KoberL .Aclinicaltrialofdofetilideinpatientswithacutemyocardialinfarctionandleftventriculardysfunction:theDIAMONDMIstudy.EuroHeartJ ,1998,19(suppl):S90.
- 17PetersenP ,GrindM ,AdlerJ,etal.Ximelagatranversuswarfarinforstrokepreventioninpatientswithnonvalvularatrialfibrillation.SPORTIFII:adose guiding,tolerability,andsafetystudy.JAmCollCardiol,2003,41:14451451.